BIM
MACK

Bogle Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bogle Investment Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-84,519
Closed -$681K – 442
2017
Q4 		$681K Buy
+84,519
New +$681K 0.05% 232